Phase 4 Breast Cancer Trial, Not Yet Recruiting NCT07254221 Sponsor: Shiraz University of Medical Sciences Condition: Breast Cancer
Back to Breast Cancer

Phase 4 Breast Cancer Trial, Not Yet Recruiting

NCT07254221
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 or older
  • People with a confirmed breast cancer diagnosis based on imaging and pathology results
  • People who are about to receive their first course of a type of chemotherapy called anthracycline-based chemotherapy

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose heart pumping function (measured as LVEF) is below 50% at the start of the trial
  • People who are currently taking a statin medication, or for whom statin use is recommended based on medical guidelines
  • People with a history of heart failure or a condition where the heart muscle is weakened or damaged (cardiomyopathy)
  • People who are pregnant or breastfeeding
  • People who are unable to give their own informed consent to participate
  • People with unexplained, ongoing high levels of certain liver enzymes (more than 3 times the normal upper limit)
  • People currently taking an oral medication called cyclosporine at the same time
  • People whose cancer has spread to other organs in the body
  • People who have already had previous cycles of chemotherapy
  • People for whom statin use is not medically safe for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Shiraz University of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
21 April 2028

Where this trial is recruiting

Iran

Primary endpoints

CTRCD (cancer treatment-related cardiac dysfunction)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov